Page last updated: 2024-08-26

9-hydroxyellipticine and Carcinoma, Lewis Lung

9-hydroxyellipticine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakanishi, N; Ohashi, M; Sugikawa, E1

Other Studies

1 other study(ies) available for 9-hydroxyellipticine and Carcinoma, Lewis Lung

ArticleYear
Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:9

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; CDC2-CDC28 Kinases; Cell Death; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Ellipticines; Enzyme Inhibitors; Histones; Humans; Mice; Mice, Inbred Strains; Microsomes; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1995